Search Results - "Bechwar, Julia"
-
1
Different lanthanide elements induce strong gene expression changes in a lanthanide-accumulating methylotroph
Published in Microbiology spectrum (12-12-2023)“…Since its discovery, Ln-dependent metabolism in bacteria attracted a lot of attention due to its bio-metallurgical application potential regarding Ln recycling…”
Get full text
Journal Article -
2
Changes in growth, lanthanide binding, and gene expression in Pseudomonas alloputida KT2440 in response to light and heavy lanthanides
Published in mSphere (29-10-2024)“…KT2440 is a ubiquitous, soil-dwelling bacterium that metabolizes recalcitrant and volatile carbon sources. The latter is utilized by two redundant, Ca- and…”
Get full text
Journal Article -
3
Chronic hepatitis E virus-induced spinal cord atrophy in a patient with chronic lymphatic leukemia: a case report and interdisciplinary management proposal
Published in Frontiers in immunology (26-07-2024)“…The hepatitis E virus (HEV) can cause acute viral hepatitis with or without neurological manifestations, and occasionally progresses to chronic infection in…”
Get full text
Journal Article -
4
Synergistic Effects of the RARalpha Agonist Tamibarotene and the Menin Inhibitor Revumenib in Acute Myeloid Leukemia Cells with KMT2A Rearrangement or NPM1 Mutation
Published in Cancers (01-04-2024)“…Inhibition of menin in acute myeloid leukemia (AML) harboring histone-lysine-N-methyltransferase 2A rearrangement (KMT2Ar) or the mutated Nucleophosmin gene…”
Get full text
Journal Article -
5
Synergistic Effects of the RARIalpha/I Agonist Tamibarotene and the Menin Inhibitor Revumenib in Acute Myeloid Leukemia Cells with KMT2A Rearrangement or NPM1 Mutation
Published in Cancers (01-04-2024)“…This study investigates the combined therapeutic potential of revumenib and tamibarotene in acute myeloid leukemia (AML) with…”
Get full text
Journal Article -
6
Synergistic Effects of the RAR alpha Agonist Tamibarotene and the Menin Inhibitor Revumenib in Acute Myeloid Leukemia Cells with KMT2A Rearrangement or NPM1 Mutation
Published in Cancers (28-03-2024)“…Inhibition of menin in acute myeloid leukemia (AML) harboring histone-lysine- -methyltransferase 2A rearrangement (KMT2Ar) or the mutated Nucleophosmin gene…”
Get full text
Journal Article